News from NORD

Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone

Publish date: April 14, 2017

 

The Foundation for Prader-Willi Research has published a blog and brochure regarding recent findings related to use of growth hormone for those affected by Prader-Willi syndrome.

Recommended Reading

Osilodrostat maintained cortisol control in Cushing’s syndrome
MDedge Family Medicine
FDA approves first home genetic health risk test
MDedge Family Medicine
Most children with growth disorders benefit from growth hormone
MDedge Family Medicine
NORD Announces Recipients of 2017 Rare Impact Awards
MDedge Family Medicine
NORD and Neurology Reviews Publish Special Report
MDedge Family Medicine
Save the Date for the 2017 NORD Summit
MDedge Family Medicine
Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Family Medicine
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Family Medicine
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Family Medicine
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Family Medicine